Gene Green

Reforms done for the right reasons and nuance in an intelligence way can truly improve how CMS ensures that payments to Medicaid providers are sufficient and enforce equal access to Medicaid beneficiaries.

I take issue with assertions of some of my colleagues that we have an ideological opposition to the ACA to seek to falsify, portray the eligibility enrollment system.

Frankly, you couldn't survive a primary if you did.

I have to admit, the hearing this morning is--I am disappointed, because for one thing, our office didn't get the GAO report within the 48 hours we should have had to be able to properly prepare.

Procedures choosing Part D plans transparency and ease of understanding are critical to ensure every beneficiary selects the plan that is most appropriate for that individual.

The CBO estimates that last year Medicare Part D spent $65 billion on prescription drugs.

One of the great successes of the Affordable Care Act is that it not only provided lifesaving health insurance coverage to millions of Americans but it also changed the way we pay for health care.

The costs for medication adherence include increased hospitalizations, doctor and emergency room visits and preventable disease regression.

As we know, the Centers for Disease Control and Prevention declared our nation's prescription drug abuse crisis an epidemic.

It is critical that we approach this challenge through a public health lens.

Despite universal recognition of the problem, our current efforts are not enough to meet the challenges of the crisis.

Current research suggests that the most effective treatment to combat opioid addiction is a combination of medication and counseling.

This is a battle we have waged for more than 100 years.

Few programs have improved the lives of Americans as significantly as Medicare.

We are here to examine four bipartisan bills, each of which makes key improvements in the Medicaid program.

The Ensuring Access to Clinical Trials Act, introduced by Representative Lloyd Doggett, allows patients with rare diseases to participate in and benefit from clinical trials without risk of losing critical benefits.

I believe H.R. 209 highlights another area in which the committee must work research on rare diseases.

The committee has received no evidence to substantiate the allegations that Planned Parenthood has engaged in the sale of fetal tissue for profit.

Unfortunately, instead of using this time to advance legislation that improves our healthcare system, we are here in response to an aggressive smear campaign against Planned Parenthood based on highly edited videos that misrepresent the…

We should not continue to play politics with women's health.

This is unprecedented, what you have done.

So if you see Planned Parenthood being wiped off the face of the country, one thing that will happen for sure is millions more unintended pregnancies and possibly close to a million more abortions because services will just not be…

These two bills are transparent efforts to give politicians power to block women's access to their doctor of choice, jeopardizing the ability of millions of low-income Medicaid beneficiaries to see the provider they trust for high-quality…

These bills fly in the face of a patient's choice and give politicians unchecked power to deny women access to the doctor of their choosing.

The Affordable Care Act included the most significant changes to the program since its creation.